Nonviral gene therapy delayed the onset of some degenerative
eye disorders such as retinal degeneration and
helped to preserve vision in an animal model.1
Researchers at Tufts University School of Medicine and the
Sackler School of Graduate Biomedical …
LASIK-induced monovision increases spectacle independence
and is a valid option for myopic patients with
presbyopia, according to a study in the American Journal of
Ophthalmology.1
The prospective, observational study examined 37 consecutive
patients o…
Surgical implantation of biosynthetic corneas may
restore vision and promote nerve regeneration in
patients with corneal damage and significant vision loss,
according to results of a 2-year clinical study.1
In the phase 1, investigator-sponsored study,…
Implantation of multifocal IOLs following cataract
extraction may result in more frequent Nd:YAG laser capsulotomies
than monofocal IOLs, according to a retrospective
study in the Journal of Refractive Surgery.1
Patients underwent cataract extraction a…
Allergan, Inc. (Irvine, CA), announced that the FDA has
approved Lumigan 0.01% as a first-line therapy to reduce
elevated IOP in patients with open-angle glaucoma or ocular
hypertension. Lumigan 0.01%, a bimatoprost ophthalmic
solution, is a reformulat…
Using a tunneled scleral injection technique may
increase IOP in patients with age-related macular degeneration
(AMD), according to a study published in Graefe’s
Archive for Clinical and Experimental Ophthalmology.
Forty-five eyes (45 patients) with …